A1188 - Early outcomes from a phase II randomized trial testing stereotactic body radiation therapy in patients undergoing I line treatment with abiraterone acetate for oligometastatic castration resistant prostate cancer (ARTO trial-NCT03449719)

Saved in:
Bibliographic Details
Published inEuropean urology Vol. 83; pp. S1716 - S1717
Main Authors Francolini, G., Allegra, A.G., Caini, S., Detti, B., Di Cataldo, V., Alitto, A., Parisi, S., D’Angelillo, R.M., Bruni, A., Ingrosso, G., Timon, G., Burchini, L., Frosini, G., Valzano, M., Ganovelli, M., Desideri, I., Visani, L., Olmetto, E., Becherini, C., Salvestrini, V., Lapini, A., Meattini, I., Livi, L.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.02.2023
Online AccessGet full text

Cover

More Information
ISSN:0302-2838
1873-7560
DOI:10.1016/S0302-2838(23)01226-5